ロード中...
Successful treatment of congestive heart failure with concomitant administration of tolvaptan to enhance the effects of furosemide
Tolvaptan (TLV), which is an antagonist to the vasopressin V2 receptor, was approved by Japanese authorities for the treatment of “volume overload in heart failure when adequate response is not obtained with other diuretics (e.g. loop diuretics)”. An 82-year-old female Japanese patient was admitted...
保存先:
| 出版年: | J Cardiol Cases |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Japanese College of Cardiology
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277594/ https://ncbi.nlm.nih.gov/pubmed/30546768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2013.07.005 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|